MedPath

West China Hospital of Sichuan University (Sichuan International Hospital)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis

Not Applicable
Not yet recruiting
Conditions
Portal Vein Thrombosis
Portal Hypertension
Portosystemic Shunt
Esophageal Varix Bleeding
Interventions
Procedure: standard second prophylaxis
Procedure: preemptive TIPS
First Posted Date
2023-11-08
Last Posted Date
2023-11-08
Lead Sponsor
West China Hospital
Target Recruit Count
120
Registration Number
NCT06122753
Locations
🇨🇳

West China Hospital of Sichuan University, Chengdu, Sichuan, China

A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)

Phase 1
Recruiting
Conditions
Duchenne Muscular Dystrophy
Interventions
Biological: JWK007 Single intravenous infusion administration
First Posted Date
2023-11-02
Last Posted Date
2024-01-17
Lead Sponsor
West China Hospital
Target Recruit Count
6
Registration Number
NCT06114056
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas

Phase 1
Recruiting
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
First Posted Date
2023-10-31
Last Posted Date
2024-07-23
Lead Sponsor
West China Hospital
Target Recruit Count
6
Registration Number
NCT06109207
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

The Application of Novel Oncolytic Virus in Late Stage Solid Tumors

Phase 1
Recruiting
Conditions
Malignant Tumor
Interventions
Drug: Oncolytic Virus YD06-1
Drug: Oncolytic Virus SDJ001
First Posted Date
2023-10-12
Last Posted Date
2023-10-12
Lead Sponsor
West China Hospital
Target Recruit Count
24
Registration Number
NCT06080984
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

Miscarriage Preventing Herbal Medicines and the Risk of Birth Defects: a Population-based Cohort Study

Active, not recruiting
Conditions
Drug Exposures
Pregnancy
Birth Defects
Interventions
Drug: Herbal medicines (e.g., Yunkang granules, Duzhong granules)
First Posted Date
2023-09-21
Last Posted Date
2024-05-07
Lead Sponsor
West China Hospital
Target Recruit Count
200000
Registration Number
NCT06048276
Locations
🇨🇳

Xiamen Health and Medical Big Data Center, Xiamen, Fujian, China

The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery

Not Applicable
Recruiting
Conditions
Colorectal Cancer
Interventions
First Posted Date
2023-08-23
Last Posted Date
2024-04-18
Lead Sponsor
West China Hospital
Target Recruit Count
9
Registration Number
NCT06006026
Locations
🇨🇳

West China hospital, Chengdu, China

RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer

Phase 2
Not yet recruiting
Conditions
Non-muscle Invasive Bladder Cancer
Interventions
First Posted Date
2023-08-18
Last Posted Date
2023-08-18
Lead Sponsor
West China Hospital
Target Recruit Count
77
Registration Number
NCT05996952
Locations
🇨🇳

West China Hospital, Chengdu, Sichuan, China

Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer

Phase 2
Recruiting
Conditions
Cholangiocarcinoma Non-resectable
Interventions
First Posted Date
2023-08-07
Last Posted Date
2023-08-07
Lead Sponsor
West China Hospital
Target Recruit Count
65
Registration Number
NCT05978609
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

Effect of Concentrated Growth Factors on Healing of Apicomarginal Defects: a Prospective Study

Not Applicable
Recruiting
Conditions
Bone Substitute
Concentrated Growth Factor
Interventions
Other: bone substitute
Other: concentrated growth factor
Combination Product: concentrated growth factor + bone substitute
First Posted Date
2023-07-11
Last Posted Date
2023-09-21
Lead Sponsor
West China Hospital
Target Recruit Count
72
Registration Number
NCT05938907
Locations
🇨🇳

First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China

Effect of Lidocaine on Postoperative Pain in Elderlypatients Undergoing Colorectal Cancer Surgery

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Drug: Placebo
First Posted Date
2023-06-27
Last Posted Date
2025-02-19
Lead Sponsor
West China Hospital
Target Recruit Count
276
Registration Number
NCT05920980
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath